Few industries offer the promise and pitfalls of biotechnology. Clinical wins and losses can lead to extraordinary stock gains or falls that make the sector best suited for only the most risk-tolerant investor. However, for investors willing to take on that risk, our Motley Fool contributors believe these three biotech stocks could offer significant opportunities in the coming year.Brian Orelli […]
Stock market today, December 26, 2014: Good morning! U.S. stock futures for Friday, Dec. 26, forecasted a 31-point gain. On Wednesday, the Dow Jones Industrial Average rose six points to close at a record high. Investor optimism continued on news that the economy is strengthening. Third-quarter GDP hit 5%, while the U.S. economy has seen 2.7 million new jobs added this year – its best […]
US stock market hits milestone following surge in economic growthPublished time: December 23, 2014 22:09Get short URLReuters / Hannibal HanschkeTagsEconomy, Inflation , Interest Rates, Investment, Oil, Real Estate, Retail, USAThe US stock market hit a historic milestone on Tuesday, following an announcement that the country’s economy grew five percent between the months of July and October ‒ its fastest pace […]
Source: Flickr user Mark EsauBargain hunters are often attracted to beaten-down biotech stocks because they sometimes rebound in astonishing fashion. That said, it can be extremely difficult to separate the wheat from the chaff when mulling over such companies, with many of them having little to no hope of ever reliving their glory days.Aegerion Pharmaceuticals , MannKind Corp. , and […]
MacleansThere’s mania in China right now. Stock market mania. It’s a bull market—niu shi— and people are excited.Read Full Article ››TAGGED:China, Scott Cendrowski, Stock Market
RECOMMENDED ARTICLES
December 19, 2014Should the U.S. Rely on a New Banker?William Pesek, Bloomberg
The bizarre spectacle of America’s top diplomat jingling the beggar’s cup in front of a rising rival enraged conservatives — and rightfully so. The […]
Alibaba founder Jack Ma celebrates its September IPO at the New York Stock Exchange. (AP Photo/Mark Lennihan)
The IPO market is about to put a bow on its busiest year since 2000, but despite a number of huge successes the figures underlying a banner year show new entrants to the market are facing tougher grading from investors.With 273 U.S. IPOs […]
NEW YORKThe stock market has gotten a bit more finicky over the past week, and that begs the question of whether or not investors could be in for a rocky start to 2015.If so, investors should be putting together their plans for handling a market drop now, rather than risk reacting poorly when the tape is tumbling. With that in […]
Source: MercK & Co.,Just when it looked as though the stock market couldn’t possibly finish the year higher, after its swoon in October, it proved the naysayers wrong. As of this writing, the S&P 500 has risen by 11% for the year, a tad bit higher than the stock markets’ historic annual return.But if you think that’s a solid return, […]
Source: Biogen IdecAs the year begins to come to a close, biotechnology investors are right to wonder what stocks may be worth owning as we head into 2015. We asked three of our Motley Fool analysts to tell us which three biotechnology stocks will be in their stockings this holiday season. Read on to see which three companies they chose.Cheryl […]
The Keystone Speculator™: Keystone’s December Seasonality Factors for Trading the Markets
Keystone’s December Seasonality Factors for Trading the MarketsThe turkey leftovers are long gone as the aroma of freshly baked Christmas cookies fills the air. The December winds are blowing now with less than four weeks of trading remaining in 2014. Markets are closed on Thursday, 12/25/14, for the Christmas holiday. […]
